Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
110.73B | 112.04B | 105.16B | 98.82B | 92.94B | 104.15B | Gross Profit |
15.36B | 16.48B | 15.23B | 15.08B | 14.02B | 16.98B | EBIT |
388.00M | 2.39B | 694.00M | 1.11B | 710.00M | 2.41B | EBITDA |
5.73B | 10.50B | 8.41B | 9.00B | 8.37B | 9.73B | Net Income Common Stockholders |
-3.15B | 1.75B | 399.00M | 621.00M | 300.00M | 991.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.15B | 21.11B | 16.95B | 20.25B | 21.31B | 12.69B | Total Assets |
87.53B | 119.46B | 113.77B | 114.38B | 113.73B | 106.30B | Total Debt |
25.49B | 22.68B | 22.81B | 25.46B | 28.34B | 19.30B | Net Debt |
10.81B | 1.57B | 5.86B | 5.21B | 7.03B | 6.61B | Total Liabilities |
44.52B | 46.87B | 46.69B | 48.08B | 49.39B | 43.02B | Stockholders Equity |
42.69B | 72.01B | 66.58B | 65.79B | 63.73B | 62.58B |
Cash Flow | Free Cash Flow | ||||
0.00 | 4.62B | 200.00M | 2.49B | 559.00M | 3.11B | Operating Cash Flow |
0.00 | 10.74B | 5.87B | 7.10B | 5.64B | 9.79B | Investing Cash Flow |
0.00 | -6.22B | -5.84B | -4.72B | -5.13B | -7.50B | Financing Cash Flow |
0.00 | -1.01B | -4.03B | -3.73B | 8.54B | -2.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.53B | 4.42 | 4.93% | 1.49% | 93.90% | ||
76 Outperform | ¥24.88B | 7.25 | 5.06% | 0.36% | 242.74% | ||
74 Outperform | ¥16.00B | 7.31 | 2.87% | -5.40% | ― | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
54 Neutral | ¥18.45B | ― | 3.14% | 0.66% | -340.28% | ||
53 Neutral | ¥8.14B | ― | 2.79% | -3.96% | -462.49% | ||
48 Neutral | ¥21.18B | ― | 3.51% | -1.68% | -240.66% |